Overview (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
Dec. 31, 2016 |
Dec. 31, 2016 |
|
| Amortization expense | $ 1,100,000 | $ 900,000 | ||
| Intangible asset | $ 11,600,000 | |||
| Non-cash impairment charge | $ 12,000,000 | |||
| Amortization expense | 1,115,000 | 897,000 | ||
| Barrett's and Thyroid Intangible Assets [Member] | ||||
| Amortization expense | 100,000 | 100,000 | $ 11,600,000 | |
| Barrett's and Thyroid [Member] | ||||
| Amortization expense | $ 100,000 | $ 100,000 | ||
| X | ||||||||||
- Definition Non-cash impairment charge. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|